ZEALAND PHARMA A S's ticker is ZEAL and the CUSIP is 98920Y304. A total of 15 filers reported holding ZEALAND PHARMA A S in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $618,000 | -30.6% | 17,205 | -25.8% | 0.00% | 0.0% |
| Q3 2020 | $891,000 | -2.1% | 23,200 | -10.8% | 0.00% | 0.0% |
| Q2 2020 | $910,000 | -5.8% | 26,000 | -7.1% | 0.00% | 0.0% |
| Q1 2020 | $966,000 | +4.0% | 28,000 | +0.1% | 0.00% | 0.0% |
| Q4 2019 | $929,000 | +245.4% | 27,978 | +163.9% | 0.00% | – |
| Q3 2019 | $269,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 510,000 | $18,329,000 | 0.11% |
| AWM Investment Company, Inc. | 19,981 | $718,000 | 0.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 5,653 | $203,000 | 0.06% |
| WELLINGTON MANAGEMENT GROUP LLP | 1,099,546 | $39,517,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 10,000 | $359,000 | 0.00% |
| Winslow, Evans & Crocker, Inc. | 235 | $8,000 | 0.00% |
| Renaissance Technologies | 17,205 | $618,000 | 0.00% |
| JANE STREET GROUP, LLC | 35,707 | $1,283,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Parallel Advisors, LLC | 94 | $3,000 | 0.00% |